BR112016018056A2 - Formas cristalinas de dolutegravir sódico e processos para suas preparações - Google Patents
Formas cristalinas de dolutegravir sódico e processos para suas preparaçõesInfo
- Publication number
- BR112016018056A2 BR112016018056A2 BR112016018056A BR112016018056A BR112016018056A2 BR 112016018056 A2 BR112016018056 A2 BR 112016018056A2 BR 112016018056 A BR112016018056 A BR 112016018056A BR 112016018056 A BR112016018056 A BR 112016018056A BR 112016018056 A2 BR112016018056 A2 BR 112016018056A2
- Authority
- BR
- Brazil
- Prior art keywords
- processes
- crystalline forms
- preparations
- dolutegravir sodium
- sodium
- Prior art date
Links
- 229960001976 dolutegravir sodium Drugs 0.000 title abstract 4
- UGWJRRXTMKRYNK-VSLILLSYSA-M dolutegravir sodium Chemical compound [Na+].C([C@@H]1OCC[C@H](N1C(=O)C1=C([O-])C2=O)C)N1C=C2C(=O)NCC1=CC=C(F)C=C1F UGWJRRXTMKRYNK-VSLILLSYSA-M 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 3
- 238000002360 preparation method Methods 0.000 title abstract 3
- -1 Sodium -2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazin-7-olate Chemical compound 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN455MU2014 IN2014MU00455A (pt) | 2014-02-07 | 2015-02-04 | |
PCT/IB2015/050841 WO2015118460A1 (en) | 2014-02-07 | 2015-02-04 | Crystalline forms of dolutegravir sodium |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112016018056A2 true BR112016018056A2 (pt) | 2017-08-08 |
Family
ID=53777379
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112016018056A BR112016018056A2 (pt) | 2014-02-07 | 2015-02-04 | Formas cristalinas de dolutegravir sódico e processos para suas preparações |
Country Status (7)
Country | Link |
---|---|
US (1) | US10087193B2 (pt) |
EP (1) | EP3102582A1 (pt) |
AU (1) | AU2015215630B2 (pt) |
BR (1) | BR112016018056A2 (pt) |
CA (1) | CA2938103C (pt) |
IN (1) | IN2014MU00455A (pt) |
WO (1) | WO2015118460A1 (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107074875B (zh) * | 2014-07-29 | 2019-03-29 | 斯洛文尼亚莱柯制药股份有限公司 | 度鲁特韦钠的新水合物 |
WO2017029642A2 (en) | 2015-08-19 | 2017-02-23 | Laurus Labs Private Limited | Novel polymorphs of dolutegravir and salts thereof |
WO2017046131A1 (en) * | 2015-09-15 | 2017-03-23 | Ratiopharm Gmbh | Processes for preparing solid state forms of dolutegravir sodium |
WO2017208105A1 (en) | 2016-05-30 | 2017-12-07 | Lupin Limited | Novel crystalline form of dolutegravir sodium |
US20210040116A1 (en) | 2017-09-07 | 2021-02-11 | Cipla Limited | New Polymorphs of Dolutegravir Sodium |
US20220112212A1 (en) * | 2019-02-05 | 2022-04-14 | Msn Laboratories Private Limited, R&D Center | Novel crystalline polymorphs of sodium (4r,12as)-9-{[(2,4-difluorophenyl) methyl]carbamoyl}-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2h-pyrido [1',2':4,5]pyrazino[2,1-b][1,3]oxazin-7-olate and process for preparation thereof |
CN114213432B (zh) * | 2021-12-31 | 2023-02-17 | 瑞孚信江苏药业股份有限公司 | 度鲁特韦的制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG171308A1 (en) * | 2008-12-11 | 2011-07-28 | Shionogi & Co | Synthesis of carbamoylpyridone hiv integrase inhibitors and intermediates |
WO2013038407A1 (en) | 2011-09-14 | 2013-03-21 | Mapi Pharma Ltd. | Amorphous form of dolutegravir |
WO2015009927A1 (en) | 2013-07-17 | 2015-01-22 | Ratiopharm Gmbh | Dolutegravir salts |
WO2015019310A1 (en) | 2013-08-07 | 2015-02-12 | Mylan Laboratories Ltd | Process for the preparation of dolute-gravir and intermediates thereof |
-
2015
- 2015-02-04 CA CA2938103A patent/CA2938103C/en active Active
- 2015-02-04 IN IN455MU2014 patent/IN2014MU00455A/en unknown
- 2015-02-04 WO PCT/IB2015/050841 patent/WO2015118460A1/en active Application Filing
- 2015-02-04 BR BR112016018056A patent/BR112016018056A2/pt active Search and Examination
- 2015-02-04 EP EP15710893.7A patent/EP3102582A1/en not_active Withdrawn
- 2015-02-04 AU AU2015215630A patent/AU2015215630B2/en active Active
- 2015-02-04 US US15/114,991 patent/US10087193B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US10087193B2 (en) | 2018-10-02 |
AU2015215630B2 (en) | 2018-08-16 |
AU2015215630A1 (en) | 2016-09-22 |
IN2014MU00455A (pt) | 2015-09-25 |
WO2015118460A1 (en) | 2015-08-13 |
EP3102582A1 (en) | 2016-12-14 |
CA2938103A1 (en) | 2015-08-13 |
CA2938103C (en) | 2021-08-10 |
US20160347766A1 (en) | 2016-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112016018056A2 (pt) | Formas cristalinas de dolutegravir sódico e processos para suas preparações | |
BR112016029605A8 (pt) | (2r, 5s, 13ar) -7,9-dioxo-10-((2,4,6-trifluorobenzil) carbamoil) -2, 3, 4, 5, 7, 9, 13, 13a-octa-hidro-2, 5-metanopirido [1',2': 4,5] pirazino [2,1-b] [1,3] oxazepin-8-olato de sódio, seu uso e composição farmacêutica | |
ECSP23088864A (es) | Derivados de 2,2-difluoropropanamida y metil bardoxolona, formas polimórficas y métodos de uso | |
NI201700096A (es) | Derivados de 4h-pirrol[3, 2-c]piridin-4-ona | |
MA40236A (fr) | Formes cristallines de (2r,5s,13ar)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-méthanpyrido[1',2':4,5]pyrazino 2,1-b][1,3]oxazépine-10-carboxamide | |
CO2018000350A2 (es) | Forma cristalina de la plinabulina monohidratada, composiciones que la comprenden y procedimientos de elaboración | |
DOP2014000255A (es) | Uracilos sustituidos bicíclicamente y uso de los mismos | |
UY36737A (es) | 3-amino-1,5,6,7-tetrahidro-4h-indol-4-onas | |
ECSP19089214A (es) | Inhibidores de quinasa y usos de los mismos | |
ECSP18074962A (es) | Derivados de aminotiazol útiles como agentes antivíricos | |
UY35745A (es) | Derivados sustituidos de fenilalanina | |
MX368582B (es) | Extracto de gardenia para colorear la piel. | |
CL2018002368A1 (es) | Formulaciones de oritavancina | |
CO2019011227A2 (es) | N-ariletil-2-aminoquinolin-4-carboxamidas sustituidas y su uso | |
UY38217A (es) | Derivados de 1-imidazotiadiazol-2h-pirrol-5-ona | |
AR101240A1 (es) | Formas cristalinas de (2r,5s,13ar)-8-hidroxi-7,9-dioxo-n-(2,4,6-trifluorobencil)-2,3,4,5,7,9,13,13a-octahidro-2,5-metanopirido[1,2,4,5]pirazino[2,1-b][1,3]oxazapina-10-carboxamida |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B15K | Others concerning applications: alteration of classification |
Free format text: A CLASSIFICACAO ANTERIOR ERA: C07D 498/14 Ipc: C07D 498/14 (2006.01), C07B 63/00 (2006.01), A61P |
|
B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] |
Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO EM FUNCAO DA REVOGACAO DO ART. 229-C DA LEI NO 9.279, DE 1996, POR FORCA DA LEI NO 14.195, DE 2021 |
|
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] |